ALN-RSV01
ALN-RSV01-105
Phase 2 small_molecule completed
Quick answer
ALN-RSV01 for Respiratory Syncytial Virus Infections is a Phase 2 program (small_molecule) at Alnylam Netherlands B.V. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Respiratory Syncytial Virus Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed